Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,151) with videos related to
Page
of 116
Sort By:
Oncotarget
|
April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities
Zenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Gynecologic Oncology
|
September 9, 2019
Defining the molecular evolution of extrauterine high grade serous carcinoma
James P Beirne, Darragh G McArt, Aideen Roddy, et al.
Diseases of the Colon and Rectum
|
January 6, 2022
Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management
Jelena Lukovic, J John Kim, Zhihui Amy Liu, et al.
Pain
|
November 29, 2016
Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles
Ralf Baron, Christoph Maier, Nadine Attal, et al.
Analytical Chemistry
|
April 22, 2011
Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine
Cindy L Moran, Vi-Huyen Le, Krishna C Chimalakonda, et al.
ESMO Open
|
May 14, 2024
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
M A Baxter, L C Spender, D Cairns, et al.
British Journal of Cancer
|
November 3, 2021
Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer
Eileen E Parkes, Kienan I Savage, Tong Lioe, et al.
The Journal of Infectious Diseases
|
July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
Nature Medicine
|
January 3, 2025
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir
M Ali Rai, Jana Blazkova, Lela Kardava, et al.
Oncotarget
|
May 3, 2018
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma
Jaine K Blayney, Lauren Cairns, Gerald Li, et al.
Page
of 116
Search research articles
Search
Showing results (1061-1070 of 1,151) with videos related to
Sort By:
Page
of 116
Oncotarget
|
April 19, 2014
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities
Zenobia C D'Costa, Catherine Higgins, Chee Wee Ong, et al.
Gynecologic Oncology
|
September 9, 2019
Defining the molecular evolution of extrauterine high grade serous carcinoma
James P Beirne, Darragh G McArt, Aideen Roddy, et al.
Diseases of the Colon and Rectum
|
January 6, 2022
Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management
Jelena Lukovic, J John Kim, Zhihui Amy Liu, et al.
Pain
|
November 29, 2016
Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles
Ralf Baron, Christoph Maier, Nadine Attal, et al.
Analytical Chemistry
|
April 22, 2011
Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine
Cindy L Moran, Vi-Huyen Le, Krishna C Chimalakonda, et al.
ESMO Open
|
May 14, 2024
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
M A Baxter, L C Spender, D Cairns, et al.
British Journal of Cancer
|
November 3, 2021
Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer
Eileen E Parkes, Kienan I Savage, Tong Lioe, et al.
The Journal of Infectious Diseases
|
July 19, 2021
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, et al.
Nature Medicine
|
January 3, 2025
Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir
M Ali Rai, Jana Blazkova, Lela Kardava, et al.
Oncotarget
|
May 3, 2018
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma
Jaine K Blayney, Lauren Cairns, Gerald Li, et al.
Page
of 116